
Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)
Author(s) -
Elizabeth Yeu,
David Wirta,
Paul Karpecki,
Stephanie N. Baba,
Mark Holdbrook
Publication year - 2022
Publication title -
cornea
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.274
H-Index - 117
eISSN - 1536-4798
pISSN - 0277-3740
DOI - 10.1097/ico.0000000000003097
Subject(s) - medicine , demodex , erythema , blepharitis , randomized controlled trial , adverse effect , dermatology , surgery , prospective cohort study , mite , botany , biology